Correction: HP1β is a biomarker for breast cancer prognosis and PARP inhibitor therapy(PLoS ONE (2015) 10:3 (e0121207) 10.1371/journal.pone.0121207)

Young Ho Lee, Xiyong Liu, Fuming Qiu, Timothy R. O'Connor, Yun Yen, David K. Ann

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Correction: HP1β is a biomarker for breast cancer prognosis and PARP inhibitor therapy(PLoS ONE (2015) 10:3 (e0121207) 10.1371/journal.pone.0121207)'. Together they form a unique fingerprint.